Syndax Pharmaceuticals In...
(SNDX)
undefined
undefined%
At close: undefined
13.07
0.00%
After-hours Dec 24, 2024, 01:22 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -209.36M | -149.34M | 24.93M | -73.16M | -56.05M | -73.96M | -60.80M | -44.47M | -24.12M | -19.83M | -14.17M | -9.96M | -13.09M |
| Depreciation & Amortization | 12.00K | 33.00K | 43.00K | 89.00K | 92.00K | 78.00K | 76.00K | 89.00K | 21.00K | 15.00K | 13.00K | 34.00K | 51.00K |
| Stock-Based Compensation | 30.95M | 16.02M | 13.32M | 9.06M | 6.00M | 6.20M | 5.45M | 4.71M | 3.88M | 2.26M | 1.42M | 139.00K | - |
| Other Working Capital | 26.25M | 2.98M | -11.76M | -5.26M | -4.98M | 490.00K | 7.87M | 1.99M | 13.52M | 1.28M | 317.00K | 858.00K | 467.00K |
| Other Non-Cash Items | -14.06M | -2.04M | 187.00K | 816.00K | 359.00K | 11.00K | 8.00K | 25.00K | 762.00K | 40.00K | 3.73M | 3.13M | 2.88M |
| Deferred Income Tax | - | - | 255.00K | -130.00K | -780.00K | -558.00K | 223.00K | 1.58M | 2.47M | 2.57M | 1.69M | -3.44M | - |
| Change in Working Capital | 31.86M | 1.66M | -9.60M | -7.93M | -241.00K | -302.00K | 7.67M | 2.92M | 14.56M | 551.00K | 31.00K | 823.00K | 141.00K |
| Operating Cash Flow | -160.60M | -133.68M | 29.13M | -71.26M | -50.61M | -68.53M | -47.37M | -35.16M | -2.43M | -14.39M | -7.29M | -9.28M | -10.02M |
| Capital Expenditures | - | -225.00K | -129.00K | - | - | -187.00K | -84.00K | -261.00K | -49.00K | -4.00K | -38.00K | -11.00K | -8.00K |
| Acquisitions | - | 225.00K | 40.74K | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | -354.61M | -495.35M | -294.72M | -278.94M | -104.02M | -78.84M | -152.26M | -158.32M | -102.01M | -3.39M | -4.02M | - | -500.00K |
| Sales Maturities Of Investments | 472.21M | 308.93M | 253.97M | 136.41M | 116.80M | 130.43M | 135.28M | 140.30M | 40.51M | 5.29M | - | 500.00K | 2.75M |
| Other Investing Acitivies | - | 225.00K | -40.74K | -142.53K | 12.78K | 51.59K | 45.00K | -97.00K | -118.00K | -1K | 33.00K | 5.00K | -50.00K |
| Investing Cash Flow | 117.61M | -186.19M | -40.87M | -142.53M | 12.78M | 51.40M | -17.03M | -18.38M | -61.67M | 1.89M | -4.03M | 494.00K | 2.19M |
| Debt Repayment | - | -21.00M | - | 19.73M | - | - | - | - | -9.00M | 14.00M | -3.68M | 6.31M | 8.63M |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | -2.60M | - | - | - | - | - |
| Other Financial Acitivies | 6.04M | 11.86M | 32.13M | 6.63M | 360.00K | 232.00K | 374.00K | 4.65M | 86.27M | -1.59M | 50.68M | -597.00K | - |
| Financial Cash Flow | 264.13M | 172.25M | 118.46M | 304.42M | 28.57M | 15.73M | 75.72M | 54.20M | 77.27M | 12.41M | 20.89M | 5.71M | 8.63M |
| Net Cash Flow | 221.14M | -147.61M | 106.72M | 90.63M | -9.26M | -1.40M | 11.32M | 665.00K | 13.17M | -95.00K | 9.57M | -3.08M | - |
| Free Cash Flow | -160.60M | -133.90M | 29.00M | -71.26M | -50.61M | -68.72M | -47.45M | -35.42M | -2.48M | -14.40M | -7.33M | -9.29M | -10.03M |